2026

Regulatory Approvals

FDA approves Outlook Therapeutics’ LYTENAVA for the treatment of wet AMD

Jul 24, 2026

FDA approves Outlook Therapeutics' LYTENAVA for the treatment of wet AMD Ophthalmology Times Europe

Credit Ratings

Fitch upgrades IFS rating of Uzbekistan-based insurer KAFOLAT

Jul 24, 2026

Fitch upgrades IFS rating of Uzbekistan-based insurer KAFOLAT Reinsurance News

Credit Ratings

Fitch downgrades utility sector outlook as $240B capex wave collides with affordability backlash

Jul 24, 2026

Fitch downgrades utility sector outlook as $240B capex wave collides with affordability backlash MarketScale

Credit Ratings

S&P Affirms Samsung Ratings, Raises Outlook to Positive; Shares Up 4%

Jul 24, 2026

S&P Affirms Samsung Ratings, Raises Outlook to Positive; Shares Up 4% Moomoo

Credit Ratings

RTD receives rating affirmations from Fitch, S&P – RTD

Jul 24, 2026

RTD receives rating affirmations from Fitch, S&P RTD-Denver

Labor

Seattle teachers authorized a strike. Here’s what they’re asking for

Labor

Fresno junior college faculty authorize strike 9 months after no-confidence vote

Regulatory Approvals

US FDA approves Takeda, Protagonist’s drug for rare blood cancer

Regulatory Approvals

FDA approves first RAS-targeting drug for pancreatic cancer